Subhasmita Bhal

Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A

C. Kundu, Subarno Paul, D. Nayak, 2022, Journal of Cell Communication and Signaling.

Organocatalyzed umpolung addition for synthesis of heterocyclic-fused arylidene-imidazolones as anticancer agents.

G. Kumar, S. K. Guchhait, Mayank Joshi, 2022, Bioorganic & medicinal chemistry.

Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics

C. Kundu, Subhasmita Bhal, 2023, Medical Oncology.

Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells.

C. Kundu, H. Patel, Saptarshi Sinha, 2023, Phytomedicine : international journal of phytotherapy and phytopharmacology.

In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin

C. Kundu, C. Karthikeyan, C. Thakur, 2024, Journal of molecular modeling.